This activity is supported by an independent education grant from Lilly. This online education program has been designed for healthcare professionals in the U.S.
Join Dr. Azizi Seixas for this CME-accredited podcast, “Navigating Social Barriers and Diagnostic Attrition,” exploring how primary care teams can help patients overcome barriers to obstructive sleep apnea (OSA) diagnosis, treatment initiation and ongoing follow-up. Through an illustrative patient scenario and insights from sleep health disparities research and community engagement, discover practical strategies to identify patients at risk, address real-world access challenges and improve continuity of care. Learn how clear communication, collaborative planning and simple systems to track referrals and results can help ensure patients receive the care they need.
Session Highlights
- Identify patients at risk: Explore practical approaches to recognizing OSA risk in high-risk populations during routine primary care visits.
- Understand barriers to diagnosis: Examine how work schedules, caregiving responsibilities, transportation, costs and healthcare access challenges can contribute to diagnostic delays.
- Support treatment and follow-up: Discover ways to improve the transition from diagnostic testing to treatment initiation and ongoing care.
- Close the loop on care: Learn how patient-centered communication, named points of contact and simple tracking processes can reduce gaps in the OSA care pathway.
Who Should Listen?
This program is designed for healthcare professionals who seek to incorporate structured OSA screening and diagnostic activation into routine cardiometabolic management workflows.
- Primary Care Physicians and Family Medicine Practitioners
- Nurse Practitioners
- Physician Assistants
Faculty
Dr. Azizi Seixas, PhD., is Interim Inaugural Chair of the Department of Informatics and Health Data Science at the University of Miami Miller School of Medicine. He is Founding Director of The Media and Innovation Lab and Associate Director of the Center for Translational Sleep and Circadian Sciences. His research focuses on sleep health, cardiometabolic and brain health, and the use of artificial intelligence and digital technologies to develop personalized health interventions. A leading advocate for health equity, Dr. Seixas works to address disparities in research and healthcare through community engagement, data science and innovative approaches to improving health outcomes. He has authored over 175 peer-reviewed publications and serves in several leadership roles within the American Academy of Sleep Medicine.
Disclosures
Partners for Advancing Clinical Education (Partners) requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships are mitigated according to Partners policies.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Partners policies. Others involved in the planning of this activity have no relevant financial relationships.
Dr Azizi Seixas faculty for this educational activity, has the following relevant financial relationships: Scientific Advisory Board; ResMed.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (Partners) and MedAll. Partners is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Education
Partners designates this live activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician Associate Continuing Education
Partners has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.75 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Nursing Continuing Professional Development
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 0.75 ANCC contact hours.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Fee Information
There is no fee for this educational activity.
This continuing education activity is active starting October 27th 2026, and will expire on July 1st 2028.